论文部分内容阅读
据国际糖尿病联盟最新的统计数据报告,2014年全世界有3.87亿糖尿病患者,并预计在2035年将有53%的增长,其中中国占很大一部分[1]。研究发现,有52.0%的糖尿病患者至少患有一种慢性并发症,21.4%的患者患有两种以上并发症[2]。而糖尿病肾病(DN)则是糖尿病最常见的微血管并发症,其中有近40%的糖尿病患者均伴有DN[3]。现有研究表明,糖脂代谢紊乱是引发和加剧糖尿病肾脏
According to the latest statistics from the International Diabetes Federation, 387 million people with diabetes worldwide in 2014 and is expected to have a 53% increase in 2035, with China accounting for a large portion. [1] The study found that 52.0% of patients with diabetes have at least one chronic complication and 21.4% have two or more complications [2]. Diabetic nephropathy (DN) is the most common microvascular complications of diabetes, of which nearly 40% of diabetic patients are associated with DN [3]. Existing research shows that glucose and lipid metabolism disorder is triggered and aggravate diabetic kidney